ArticlePest management science2026
Fendioxypyracil, a new and systemic PPO-inhibiting herbicide for X-spectrum weed control.
Article in Pest management science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFendioxypyracil is a new protoporphyrinogen oxidase (PPO; HRAC Group 14)-inhibiting herbicide developed to expand post-emergence weed control options. The compound combines a pyridine-based core with an aryloxy side chain, resulting in high biological activity. Physiological profiling and enzyme assays confirmed PPO inhibition as its mode of action, with strong inhibition of both PPO1 and PPO2 from Amaranthus tuberculatus and higher potency than saflufenacil, particularly against PPO2. Greenhouse and field studies demonstrated broad-spectrum efficacy against major broadleaf and grass weeds at low use rates. These results indicate that fendioxypyracil represents a valuable new PPO inhibitor for integrated weed management.
resultsGreenhouse evaluations demonstrated high efficacy of fendioxypyracil against key grass weeds, including wild oat (Avena fatua), crabrass (Digitaria Sanginalis), goosegrass (Eleusina indica) and barnyard grass (Echinochloa crus-galli), as well as strong control of major broadleaf species. Physiological characterization and enzyme inhibition assays confirmed PPO as the primary site and mode of action, with IC₅₀ values lower than those of the commercial standard saflufenacil for both PPO isoforms.
conclusionFendioxypyracil represents a next-generation PPO inhibitor with broad-spectrum and systemic activity, offering a valuable new tool for integrated weed management. Its high biological activity and efficacy across multiple weed taxa supports its potential to enhance on-farm weed control strategies and contributes to resistance management programs. © 2026 The Author(s). Pest Management Science published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.